The messenger RNA (mRNA) market is rapidly expanding, projected to reach $20.99 billion by 2035, driven by advancements in mRNA-based vaccines and therapeutics, particularly due to the COVID-19 pandemic. The market is led by the infectious disease sector, with North America at the forefront due to its regulatory leadership and manufacturing capabilities. Recent developments include new vaccine approvals and partnerships for improved mRNA formulations. Despite challenges such as manufacturing complexity, mRNA technology is diversifying into oncology and gene editing, presenting substantial growth opportunities for the future.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.globenewswire.com/news-release/2026/04/07/3269488/0/en/Messenger-RNA-mRNA-Market-Projected-to-Reach-20-99-Billion-by-2035-Moderna-Pfizer-and-Others-Propel-mRNA-Expansion-into-New-Therapeutic-Areas.html
